City

Sankt-Peterburg (2)

Zurich (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (2)

Patricia Schlagenhauf (1)

Collaborator

Acellena Contract Drug Research and Development (1)

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland (1)

ETH Zurich (1)

Swiss Tropical & Public Health Institute (1)

University Hospital, Geneva (1)

Intervention

placebo (2)

bvrs-gamvac (1)

bvrs-gamvac-combi (1)

observational study (1)

Study Documents

Intervention Type

other (3)

biological (1)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

mers

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

MERS (Middle East Respiratory Syndrome), MERS Trial in Sankt-Peterburg (BVRS-GamVac, )

Recruiting

MERS (Middle East Respiratory Syndrome)
MERS

BVRS-GamVac
placebo

Sankt-Peterburg, Russian Federation

Research Institute of Influenza

Jan 13, 2021

MERS (Middle East Respiratory Syndrome), MERS Trial in Sankt-Peterburg (BVRS-GamVac-Combi, )

Recruiting

MERS (Middle East Respiratory Syndrome)
MERS

BVRS-GamVac-Combi
placebo

Sankt-Peterburg, Russian Federation

ECO-Safety

Jan 13, 2021

Infection Tracking in Travellers. The Project Aims to Identify

Not yet recruiting

Travel-Related Illness
+8 more

Observational study

Zürich, Switzerland

Epidemiology, Biostatistics and Prevention Institute at the Univ

Dec 16, 2020